SEC Form 4 · accession 0001127602-17-011819
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Benkowitz
Officer — President and COO
Period of report
Mar 15, 2017
Accepted (ET)
Mar 15, 2017 · 6:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $146.03 | Mar 15, 2017 | A | 63,000 | A | Mar 15, 2018 | Mar 15, 2027 | Common Stock | 63,000 | 63,000 | D |
Explanation of responses
- F1These stock options vest in one-third increments on each of March 15, 2018, 2019 and 2020.